These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7605658)

  • 1. Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour.
    Andersen TI; Paus E; Nesland JM; McKenzie SJ; Børresen AL
    Acta Oncol; 1995; 34(4):499-504. PubMed ID: 7605658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: correlation with ERBB-2 protein expression and ERBB2 gene copy number.
    Mrhalová M; Kodet R; Kalinová M; Hilská I
    Pathol Res Pract; 2003; 199(7):453-61. PubMed ID: 14521261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers.
    Vernimmen D; Gueders M; Pisvin S; Delvenne P; Winkler R
    Br J Cancer; 2003 Sep; 89(5):899-906. PubMed ID: 12942124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amplification and overexpression of c-erbB2 in human breast cancer].
    Chen Y; Dong J; Li C
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):16-9. PubMed ID: 7656779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum c-erbB-2 in breast cancer patients.
    Watanabe N; Miyamoto M; Tokuda Y; Kubota M; Ando Y; Tajima T; Mitomi T
    Acta Oncol; 1994; 33(8):901-4. PubMed ID: 7818922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined measurement of the c-erbB-2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse.
    Sugano K; Ushiama M; Fukutomi T; Tsuda H; Kitoh T; Ohkura H
    Int J Cancer; 2000 Jul; 89(4):329-36. PubMed ID: 10956406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
    Leitzel K; Teramoto Y; Konrad K; Chinchilli VM; Volas G; Grossberg H; Harvey H; Demers L; Lipton A
    J Clin Oncol; 1995 May; 13(5):1129-35. PubMed ID: 7738618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients.
    Leitzel K; Teramoto Y; Sampson E; Mauceri J; Langton BC; Demers L; Podczaski E; Harvey H; Shambaugh S; Volas G
    J Clin Oncol; 1992 Sep; 10(9):1436-43. PubMed ID: 1355522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of serum c-erbB-2 protein in breast cancer patients.
    Willsher PC; Beaver J; Pinder S; Bell JA; Ellis IO; Blamey RW; Robertson JF
    Breast Cancer Res Treat; 1996; 40(3):251-5. PubMed ID: 8883967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1.
    Mrhalova M; Kodet R
    Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients.
    Riou G; Mathieu MC; Barrois M; Le Bihan ML; Ahomadegbe JC; Bénard J; Lê MG
    Int J Cancer; 2001 Jul; 95(4):266-70. PubMed ID: 11400121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
    Meenakshi A; Kumar RS; Kumar NS
    J Immunoassay Immunochem; 2002; 23(3):293-305. PubMed ID: 12227416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer.
    Isola JJ; Holli K; Oksa H; Teramoto Y; Kallioniemi OP
    Cancer; 1994 Feb; 73(3):652-8. PubMed ID: 7905363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues.
    Kobayashi M; Ooi A; Oda Y; Nakanishi I
    Hum Pathol; 2002 Jan; 33(1):21-8. PubMed ID: 11823970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study.
    Streckfus C; Bigler L; Dellinger T; Dai X; Kingman A; Thigpen JT
    Clin Cancer Res; 2000 Jun; 6(6):2363-70. PubMed ID: 10873088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum c-erB-2 levels in monitoring of operable breast cancer patients.
    Imoto S; Kitoh T; Hasebe T
    Jpn J Clin Oncol; 1999 Jul; 29(7):336-9. PubMed ID: 10470658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy.
    Classen S; Kopp R; Possinger K; Weidenhagen R; Eiermann W; Wilmanns W
    Tumour Biol; 2002; 23(2):70-5. PubMed ID: 12065844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?
    Underwood M; Bartlett J; Reeves J; Gardiner DS; Scott R; Cooke T
    Cancer Res; 1995 Jun; 55(11):2422-30. PubMed ID: 7757996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.